TG Therapeutics (TGTX) had the highest return in 2002 by a US stock in the Nasdaq Composite (IXIC), returning 281,150%.
| ASSET | YEAR | % RETURN |
|---|---|---|
TG Therapeutics (TGTX) | 2002 | 281,150% |
Ainos (AIMD) | 2002 | 11,300% |
Applied DNA Sciences (APDN) | 2002 | 4,900% |
NetEase (NTES) | 2002 | 1,429.37% |
Sohu (SOHU) | 2002 | 442.37% |
Marker Therapeutics (MRKR) | 2002 | 412.82% |
Royal Gold (RGLD) | 2002 | 390.58% |
Sleep Number (SNBR) | 2002 | 377.17% |
Encore Capital (ECPG) | 2002 | 323.08% |
Ziff Davis (ZD) | 2002 | 310.34% |
AYRO (AYRO) | 2002 | 275.78% |
Charles & Colvard (CTHR) | 2002 | 236.25% |
Simulations Plus (SLP) | 2002 | 182.38% |
Stonex (SNEX) | 2002 | 182.29% |
LivePerson (LPSN) | 2002 | 176.47% |
Capricor Therapeutics (CAPR) | 2002 | 174.51% |
Security National Financial (SNFCA) | 2002 | 172.58% |
PetMed Express (PETS) | 2002 | 153.42% |
US Global Investors (GROW) | 2002 | 144.92% |
Gentherm (THRM) | 2002 | 144.14% |
Pacific Premier Bancorp (PPBI) | 2002 | 142.47% |
ProPhase Labs (PRPH) | 2002 | 140.17% |
City (CHCO) | 2002 | 137.82% |
Central Garden & Pet (CENT) | 2002 | 137.31% |
Americas Car-Mart (CRMT) | 2002 | 136.11% |
